SPPL3 Antikörper (AA 213-263) (HRP)
-
- Target Alle SPPL3 Antikörper anzeigen
- SPPL3 (Signal Peptide Peptidase 3 (SPPL3))
-
Bindungsspezifität
- AA 213-263
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SPPL3 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Signal peptide peptidase-like 3 protein (213-263AA)
- Isotyp
- IgG
- Top Product
- Discover our top product SPPL3 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- SPPL3 (Signal Peptide Peptidase 3 (SPPL3))
- Andere Bezeichnung
- SPPL3 (SPPL3 Produkte)
- Synonyme
- CG17370 antikoerper, CG5901 antikoerper, Dmel\\CG17370 antikoerper, SPPL3 antikoerper, Sppl antikoerper, sppL antikoerper, RGD1562826 antikoerper, Sppl3-ps1 antikoerper, MGC52975 antikoerper, sppl3 antikoerper, MGC75937 antikoerper, fb94d08 antikoerper, wu:fb94d08 antikoerper, zgc:114093 antikoerper, 4833416I09Rik antikoerper, Psl4 antikoerper, Usmg3 antikoerper, IMP2 antikoerper, MDHV1887 antikoerper, PRO4332 antikoerper, PSH1 antikoerper, PSL4 antikoerper, Signal peptide peptidase-like antikoerper, signal peptide peptidase like 3 antikoerper, signal peptide peptidase like 3 L homeolog antikoerper, signal peptide peptidase 3 antikoerper, Intramembrane protease 2 antikoerper, SppL antikoerper, Sppl3 antikoerper, sppl3.L antikoerper, sppl3 antikoerper, SPPL3 antikoerper, imp-2 antikoerper
- Hintergrund
-
Background: Intramembrane-cleaving aspartic protease (I-CLiP) that cleaves type II membrane protein substrates in or close to their luminal transmembrane domain boundaries (PubMed:16873890, PubMed:25354954, PubMed:25827571). Acts like a sheddase by mediating the proteolytic release and secretion of active site-containing ectodomains of glycan-modifiying glycosidase and glycosyltransferase enzymes such as MGAT5, B4GAT1 and B4GALT1 (PubMed:25354954, PubMed:25827571). Catalyzes the intramembrane cleavage of the envelope glycoprotein gp130 and/or the leader peptide gp18LP of the simian foamy virus independent of prior ectodomain shedding by furin or furin-like proprotein convertase (PC)-mediated cleavage proteolysis (PubMed:23132852). May also have the ability to serve as a shedding protease for subsequent intramembrane proteolysis by SPPL2A and SPPL2B of the envelope glycoprotein gp130 (PubMed:23132852). Plays a role in the regulation of cellular glycosylation processes (PubMed:25354954). Required to link T-cell antigen receptor (TCR) and calcineurin-NFAT signaling cascades in lymphocytes by promoting the association of STIM1 and ORAI1 during store-operated calcium entry (SOCE) in a protease-independent manner (PubMed:25384971).
Aliases: SPPL3 antibody, IMP2 antibody, PSL4 antibody, Signal peptide peptidase-like 3 antibody, SPP-like 3 antibody, EC 3.4.23.- antibody, Intramembrane protease 2 antibody, IMP-2 antibody, Presenilin homologous protein 1 antibody, PSH1 antibody, Presenilin-like protein 4 antibody
- UniProt
- Q8TCT6
-